ARTICLE | Company News
Management tracks
April 14, 2015 2:25 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) hired Ramona Sequeira as president of its U.S. business unit. She succeeds Doug Cole, who stepped down March 31. Sequeira was VP of Lilly USA at Eli Lilly and Co. (NYSE:LLY).
Oncology company Blend Therapeutics Inc. (Watertown, Mass.) named Drew Fromkin president, CEO and director. Fromkin was president and CEO of Clinical Data Inc., which Forest Laboratories Inc. acquired. ...